A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are now. By Rebecca Robbins It’s easy to make a medical case for ...

A new study suggests blockbuster weight loss drugs Wegovy and Zepbound are not cost-effective at their current prices, despite the proven health benefits. The study, published in JAMA Health Forum ...

Eli Lilly is playing catch-up to Novo Nordisk in the fast-growing obesity therapy sector, but has new data that could tip the balance in its favour. The results of the first head-to-head trial of ...